Zdrowie i gospodarka · 17/08/1999
FDA Releases Revised Guidance on Reducing Risk of Creutzfeldt-Jakob Disease Transmission via Blood Products
The FDA has released a revised guidance document outlining precautionary measures to minimize the risk of Creutzfeldt-Jakob Disease (CJD) and New Variant CJD (nvCJD) transmission through blood and blood products, replacing a 1996 guidance document.